⌘K

Login Start Free

Home/Filings/4/0001235440-04-000004

4//SEC Filing

GAMZU ELKAN R 4

Accession 0001235440-04-000004

CIK 0000713275other

View on SEC.gov Company Profile

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 11:39 AM ET

Size

10.4 KB

Accession

0001235440-04-000004

Insider Transaction Report

Form 4

Period: 2004-08-17

PHARMOS CORPPARS

Director

Transactions

Sale
Common Stock
2004-08-17$3.45/sh−100$345→ 0 total
Exercise/Conversion
Stock Options
2004-08-17−1,250→ 11,500 total
Exercise: $1.02From: 2004-08-17Exp: 2013-02-17→ Common Stock (1,250 underlying)
Sale
Common Stock
2004-08-17$3.43/sh−1,150$3,945→ 100 total
Exercise/Conversion
Common Stock
2004-08-17$1.02/sh+1,250$1,275→ 1,250 total

Footnotes (2)

[F1]Sale is pursuant to a 10b5-1 trading plan previously established by Dr. Gamzu.
[F2]The 1,250 options exercied became exercisable on 8/17/04. The remaining 11,500 options become exercisable in ten equal quarterly increments between 11/17/04 and 2/17/07.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

PHARMOS CORP

CIK 0000713275

Entity typeother

Related Parties

1

filerCIK 0001235440

Filing Metadata

Form type: 4
Filed: Aug 17, 8:00 PM ET
Accepted: Aug 18, 11:39 AM ET
Size: 10.4 KB

View on SEC.gov